Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Results of a placebo­ controlled study of tasquinimod in men with metastatic castrate resistant prostate cancer

Dr Michael A. Carducci - Johns Hopkins University, Baltimore, USA
Results of a placebo­ controlled study of tasquinimod in men with metastatic castrate resistant prostate cancer ( Dr Michael A. Carducci - Johns Hopkins University, Baltimore, USA )
2 Oct 2015

ECC 2015 scientific highlights

Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden
ECC 2015 scientific highlights ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )
30 Sep 2015

Atezolizumab limits disease progression for metastatic urothelial bladder cancer

Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
Atezolizumab limits disease progression for metastatic urothelial bladder cancer ( Dr Jonathan E. Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
30 Sep 2015

Multi-peptide vaccine for kidney cancer fails to improve survival

Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA
Multi-peptide vaccine for kidney cancer fails to improve survival ( Dr Brian Rini - Cleveland Clinic Foundation, Cleveland, USA )
28 Sep 2015

ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review

Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK
ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review ( Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK )
28 Sep 2015

Comment: New immunotherapy options for kidney cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Comment: New immunotherapy options for kidney cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
26 Sep 2015

Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries

Prof Rifat Atun - Harvard University, Boston, USA
Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries ( Prof Rifat Atun - Harvard University, Boston, USA )
26 Sep 2015

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA
CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )
26 Sep 2015

METEOR trial results: Cabozantinib improves advanced kidney cancer survival

Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
METEOR trial results: Cabozantinib improves advanced kidney cancer survival ( Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
26 Sep 2015

Highlights of the p-medicine project

Highlights of the p-medicine project ( )
2 Sep 2015

The p-medicine project and ECRIN

Jacques Demotes - ECRIN
The p-medicine project and ECRIN ( Jacques Demotes - ECRIN )
2 Sep 2015

Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma

Dr James Larkin - Royal Marsden Hospital, London, UK
Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma ( Dr James Larkin - Royal Marsden Hospital, London, UK )
9 Jun 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation